The Negative Side of Cost-effectiveness Analysis

JAMA: The Journal of the American Medical Association

Volumn 277, Issue 24, 1997, Pages 1931-1932

  Stinnett, Aaron A ^a   Mullahy, John ^b  

^a JOHNSON AND JOHNSON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85008545814     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03540480031025     Document Type: Letter

References (5)

1. Sacristán JA, Obenchain RL. Reporting cost-effectiveness analyses with confidence. JAMA. 1997;277:375.
2. Van Hout BA, Malwenn JA, Gordon GS, Rutten FFH. Costs, effects, and C/E ratios alongside a clinical trial. Health Econ. 1994;3:309-319.
3. Mullahy J. What you don't know can't hurt you? statistical issues and standards for medical technology evaluation. Med Care. 1996;34:DS124-DS135.
4. Stinnett AA. Issues in the Economic Evaluation of Health Interventions. Boston, Mass: Harvard University; 1996. Thesis.
5. Pauly MV. Valuing health care benefits in money terms. In: Sloan FA, ed. Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies. New York, NY: Cambridge University Press; 1995:99-124.